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           The process of V(D)J rearrangement, by virtue 
of the relatively random nature of V, D, and J 
gene selection and junctional diversity, creates 
a wide variety of autoreactive specifi  cities (  1  ). 
In normal individuals, this does not pose a prob-
lem, because the immune system has established 
several checkpoints to ensure that autoreactive 
lymphocytes will be eliminated or controlled 
(  1, 2  ). During B cell development, reactivity to 
self-antigens is fi  rst assessed at the immature B 
cell stage in the bone marrow and then again at 
the transitional stage in the spleen. Autoreactive 
B cells at these two checkpoints can be either 
eliminated or rendered nonfunctional by clonal 
deletion or anergy; for the transitional B cells in 
the spleen, these are the predominant tolerance 
mechanisms (  3  ). However, for autoreactive B 
cells in the bone marrow, the primary mecha-
nism for removal of a self-reactive B cell receptor 
(BCR) to membrane-bound antigens is receptor 
editing (  4  –  7  ). This mechanism provides the 
cell with a new receptor through continued 
rearrangement at the light chain loci (or on 
rare occasions, at the heavy chain locus) and re-
placement of the former light chain with a new 
light chain (  8  ). Receptor editing has been shown 
to be a highly effi   cient mechanism to replace 
these autoreactive receptors with a nonself-re-
active receptor (  4, 9  –  11  ). If the new light chain 
makes a nonautoreactive receptor, the cell can 
mature and emigrate to the spleen. If receptor 
editing does not succeed in producing a new re-
ceptor that is not autoreactive, anergy or clonal 
deletion should follow (  12  ). For B cells reactive 
with soluble antigen, both receptor editing and 
anergy are used as mechanisms of central toler-
ance (  13  ). For the few autoreactive cells that do 
emerge from the bone marrow, contact with self-
antigen during the transitional B cell tolerance 
checkpoint in the spleen normally results in 
apoptosis or anergy. Which tolerance mechanism 
(receptor editing, anergy, or clonal deletion) is 
invoked is dependent not only on the maturation 
stage of the B cell but also on many other factors, 
including the nature of the antigen, the avidity 
of the BCR for the antigen, and the strength of 
the signal induced by the interaction of the 
BCR with the self-antigen. 
  Effi   cient B cell tolerance is essential to pre-
vent autoimmunity. It has been shown that over 
half of early immature B cells have self-reactive 
receptors, but at this fi  rst tolerance checkpoint 
in the bone marrow, a considerable number of 
these autoreactive specifi  cities are lost by one of 
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compartment in these mice suggests that some, presumably 
low affi   nity, autoreactive B cells exit the bone marrow in 
MRL/lpr mice. To determine whether the diff  erences in re-
ceptor editing between autoimmune and nonautoimmune 
strains also extended to nontransgenic mice, we assessed the 
transit time through the pre  –  B cell compartment (  10, 13  ). 
The more rapid transit time in nontransgenic MRL/lpr and 
MRL/+ mice compared with nontransgenic B6 bone mar-
row suggests that polyclonal nontransgenic MRL/lpr and 
MRL/+ mice may also undergo less receptor editing in vivo. 
Finally, we observed that the level of CD19 is greatly reduced 
on bone marrow cells as a result of receptor-editing signals 
in B10 transgenic mice in vivo but is reduced to a much 
lesser extent in MRL/lpr immature B cells, which is consistent 
with less receptor editing in these lupus-prone mice. Although 
we show that clonal deletion is eff  ective to a strong, memb-
rane-bound antigen in vivo, B cells with reactivity to soluble 
or weaker self-antigens may well escape from the bone marrow 
if not eliminated by receptor editing. Thus, this relative 
receptor-editing defect in lupus mice, coupled with a less 
stringent affi   nity threshold for clonal deletion, is likely to result 
in the release of some autoreactive cells from the bone marrow, 
thus providing the potential for subsequent activation by 
exposure to self-antigen. 
    RESULTS   
  MRL/lpr immature B cells undergo less receptor editing 
in an in vitro culture system 
  To directly assess whether there is a relative defect in the abil-
ity of MRL/lpr lupus-prone mice to undergo receptor edit-
ing, it was important to directly compare MRL/lpr mice with 
B10 mice in the same experimental system. Because the 3-83 
transgenic BCR reacts with H-2K  k   but not with H-2K  d  , 
we crossed B10.D2 mice bearing the 3-83 heavy and light 
chain BCR transgene with MRL/lpr mice and backcrossed 
to MRL/lpr for seven generations, screening for H-2  d   at each 
generation, to obtain MRL/lpr 3-83 BCR transgenic mice 
on the H-2  d   background. Hence, these two 3-83 transgenic 
strains bearing H-2  d   do not encounter any self-antigen in vivo. 
  We assessed the ability of both strains to undergo receptor 
editing in a previously described in vitro culture system (  18  ). 
Unfractionated bone marrow cell preparations were cultured 
for 5 d with IL-7, and because these cells were from BCR 
transgenic mice, the resulting population of cells was   >  95% 
immature B cells. IL-7 was then removed from the cultures, 
and the cells were either cultured with an irrelevant antibody 
(control culture) or with anti-Id antibody (receptor-editing 
culture). We observed that removal of IL-7 after 5 d of cul-
ture induced some      rearrangements, as assessed by real-time 
PCR. BCR ligation with the anti-Id antibody resulted in 
increased levels of endogenous      rearrangement in 3-83 
transgenic mice on the B10.D2 background, whereas lower 
levels of rearrangements were induced in the control culture 
as compared with the IL-7 cultures (  Fig. 1  ).   In contrast, the 
level of induced      rearrangement in cultures of MRL/lpr 
H-2  d   immature B cells was only marginally higher in the cultures 
these tolerance mechanisms (  1  ). Where the breakdown in 
tolerance occurs in autoimmune patients and autoimmune-
prone mice is not clear. In systemic lupus erythematosus 
(SLE), somatically mutated IgG autoantibodies against DNA 
and other nuclear components are often the pathogenic anti-
bodies found in immune complexes in the kidney, suggesting 
antigen activation and breakdown of tolerance in the periph-
ery. Indeed, an extensive study of the peripheral blood of 
three SLE patients demonstrated that the second checkpoint, 
the transition between newly emigrated B cells in the periph-
eral blood and mature naive B cells, is clearly defective in SLE 
patients (  14, 15  ). However, much less information is available 
about potential defects in the bone marrow of SLE patients or 
lupus-prone strains of mice. Most of the SLE patients in the 
study of Yurasov et al. (  14  ) also showed increases in the fre-
quency of Hep-2  –  reactive B cells and polyreactive B cells in 
newly emigrated B cells as compared with controls, although 
the increase reached the level of signifi  cance (P < 0.2) in only 
one of the patients for polyreactive antibodies. This new emi-
grant stage is particularly important, because the higher levels 
of B cell  –  activating factor in autoimmune individuals could 
thwart the second checkpoint and allow many auto  re  active 
B cells that leave the bone marrow to mature into naive B cells. 
Because the autoreactive profi  le of the newly emigrated B cells 
in normal individuals mirrors that of the immature B cells in the 
bone marrow (  1  ), these data are suggestive that central tolerance 
may have defects in SLE, although one cannot determine 
from this study if it is receptor editing or clonal deletion that 
may cause this potential defect. 
  In this study, we wished to specifi  cally ask whether re-
ceptor editing was impaired in lupus-prone mice. In two 
mouse models of autoimmunity, including the one we are 
currently studying, it has been reported that central tolerance 
to strong self-antigens is not aff  ected in vivo, as demonstrated 
by the fact that all B cells in the periphery of the mice have 
edited their receptors (  16, 17  ). However, the number of B 
cells in the spleens of those BCR transgenic mice is very low, 
suggesting that clonal deletion was the major mechanism of 
central tolerance in these mice that are unable to undergo ef-
fective receptor editing because of the inability to delete the 
randomly integrated BCR transgene. We reproduce the pub-
lished fi  ndings in this paper, but a careful inspection of several 
parameters characteristic of receptor editing in B10 and MRL/
lpr BCR transgenic mice lead us to suggest that although 
clonal deletion to this particular strong, membrane-bound 
self-antigen is intact in these mice, receptor editing is less ef-
fi  ciently induced in the MRL/lpr mice. Using an in vitro 
receptor-editing culture system, we demonstrate that imma-
ture B cells from the MRL/lpr BCR transgenic mice display 
less induced endogenous      rearrangement and less RAG 
messenger RNA (mRNA) up-regulation upon BCR stimu-
lation compared with immature B cells from the nonauto-
immune B10.D2 3-83 transgenic mice. In addition, we also 
found evidence of receptor-editing impairments in MRL/lpr 
BCR transgenic mice that are exposed to self-antigen in vivo. 
Furthermore, the diff  erent Ig    /Ig     ratio in the transitional JEM VOL. 204, November 26, 2007 
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are more refractory to BCR signaling with regard to induced 
light chain rearrangement and RAG up-regulation, we deter-
mined whether immature B cells from MRL/lpr mice were 
defective in the initial IgM down-regulation in response to sig-
naling through the BCR. We analyzed immature B cells from 
the IL-7 culture, the receptor-editing culture, and the control 
culture by fl  ow cytometry. As seen in   Fig. 2  , the mean fl  uores-
cence intensity (MFI) of IgM on immature B cells is lower on 
the MRL/lpr than on the B10.D2 cells in the IL-7 cultures, but 
both down-regulate IgM in response to anti-Id stimulation to a 
similar extent.   Thus, despite the fact that immature B cells from 
MRL/lpr mice do not respond to this BCR cross-linking with 
as robust a receptor-editing response as immature B cells from 
B10.D2, surface IgM is down-regulated similarly. 
  Greater calcium fl  ux in response to BCR ligation 
in immature B cells from MRL/lpr mice 
  Because the results from the receptor-editing cultures demon-
strate that BCR signaling of immature B cells from MRL/lpr 
transgenic mice does not induce as much endogenous light chain 
rearrangement and does not result in as much up-regulation of 
RAG mRNA compared with immature B cells from B10.D2 
transgenic mice, we tested whether immature B cells from 
MRL/lpr transgenic mice were generally hyporesponsive to sig-
nals through the BCR. Bone marrow cells from day 5 IL-7 cul-
tures were loaded with Indo-1 and subsequently stimulated with 
the varying concentrations of F(ab    )  2   anti-IgM (  Fig. 3  ).   The 
level of calcium fl  ux was measured by fl  ow cytometry. MRL/
lpr transgenic mice showed a greater calcium fl  ux compared 
with B10.D2 transgenic mice at all concentrations of anti-IgM. 
Furthermore, MRL/lpr B cells fl  uxed more calcium in response 
to low concentrations of ionomycin. Hence, the immature B 
cells from the MRL/lpr mice are hyperresponsive at a stage 
downstream of BCR signaling. 
stimulated with anti-Id as compared with the control cultures, 
suggesting that the immature B cells from MRL/lpr mice do not 
respond as effi   ciently to BCR signals by receptor editing. 
  BCR signaling in immature B cells in this culture system 
leads to up-regulation of RAG 1 and RAG 2 mRNA (  18  ). 
Therefore, using RAG up-regulation as an early marker for 
the induction of receptor editing, we tested whether B10 and 
MRL/lpr mice diff  er in the magnitude of their receptor-
editing responses. Withdrawal of IL-7 in the control cultures 
resulted in increased levels of RAG 1 and RAG 2 expression, 
but exposure to anti-Id antibody greatly increased the levels 
of RAG mRNA in B10.D2 immature B cells. However, im-
mature B cells from MRL/lpr transgenic mice did not up-
regulate their RAG expression as eff  ectively as immature B 
cells from B10.D2 transgenic mice when stimulated through 
the BCR (  Fig. 1  ). Therefore, immature B cells from MRL/
lpr transgenic mice show an overall lower level of appropriate 
responsiveness to receptor-editing signaling. 
  MRL/lpr mice down-regulate surface IgM after receptor-
editing signaling 
  When immature B cells interact with antigen, the surface IgM 
level is substantially down-regulated. Because MRL/lpr mice 
  Figure 1.     Lower level of receptor editing in cultures of MRL/lpr 
(H-2  d  ) versus B10.D2 3-83 transgenic bone marrow. (A) Level of 
 endogenous      rearrangement induced in receptor-editing bone marrow 
cultures of B10.D2 and MRL/lpr (H-2  d  ) 3-83 transgenic mice. After 5 d of 
culture with IL-7, the cells were removed from IL-7 and cultured with anti-
Id or with a control antibodies. DNA was obtained from the IL-7 culture and 
on days 1 and 2 after removal from IL-7. The fold increase   ±   SEM of      rear-
rangements in anti-Id and control cultures over the level in the IL-7 cultures 
is shown. Data are derived from 7 to 10 experiments. (B and C) Level of RAG 
1 and 2 up-regulation, respectively, in receptor-editing cultures. The fold 
increase   ±   SEM of RAG 1 and 2 mRNA in anti-Id and control cultures over 
IL-7 cultures is shown. Data are derived from 10 to 13 experiments.    
  Figure 2.     IgM is down-regulated in response to BCR ligation in 
immature B cells in bone marrow cultures of both B10.D2 and 
MRL/lpr (H-2  d  ) 3-83 transgenic mice. Immature B cells from re-
ceptor-editing and control cultures from B10.D2 and MRL/lpr (H-2  d ) 
3-83 mice were stained for surface expression of IgM after 2 d of 
culture with the anti-Id or control antibody, and the MFI   ±   SEM of 
IgM was compared between IL-7, anti-Id, and control cultures for 
each strain. Because the experiments were performed on FACSCalibur 
and LSR II instruments, with greatly varying absolute magnitudes of 
MFI, we express the data as relative MFI, with the MFI of IgM in the 
IL-7 culture from the B10.D2 transgenic mice being 100% for each 
experiment. Results are from three to experiments.     2856 REDUCED RECEPTOR EDITING IN MRL/  LPR   MICE | Lamoureux et al.
  We crossed B10.D2 3-83 transgenic mice with B10.BR 
mice, and crossed MRL/lpr H-2  d   transgenic mice with MRL/
lpr mice, resulting in F1 mice that were H-2  k/d  . Thus, all cells 
in the mouse expressed a strong self-antigen. The transgenic 
mice on the nonantigenic H-2  d   background have very few 
pro  –   or pre  –  B cells because of the presence of the rearranged 
heavy and light chain transgenes (  20  ). Hence, most bone 
marrow B progenitor cells are homogeneous in composition 
and are of the immature B cell phenotype (  Fig. 5 A  ).   In con-
trast, the majority of developing B cells in the bone marrow 
of H-2  k/d   mice of both the MRL/lpr and B10 backgrounds 
greatly down-regulate IgM in response to exposure to self-
antigen and, thus, resemble the pre  –  B cell phenotype (  Fig. 5 A  ). 
However, the down-regulation is less complete in the MRL/
lpr transgenic mice. When the IgM  +   immature B cell gate es-
tablished on nontransgenic mice was applied to the transgenic 
bone marrow CD43    −   B220  +  AA4  +   (pre  –  B cell plus immature 
B cell phenotype) cells, 6.25   ±   0.17% of B10 cells and 17.24   ±   
0.14% of MRL/lpr cells fell in the IgM  +   gate on the H2  d/k   
background, compared with    90-95% of CD43    −   B220  +  AA4  +   
B cells from either strain of transgenic mice on the H-2  d   
background (a total of 10  –  12 mice of each genotype were 
examined; Fig. 5 and not depicted). To quantify this diff  erence 
in the extent of down-regulation of IgM, we calculated the 
MFI of this population of cells.   Fig. 5 B   shows that the 
B220  +  CD3    −   AA4  +   CD43    −    cells from B10 3-83 H-2  k/d   mice 
displayed a 50-fold reduction in MFI for IgM compared with 
B10.D2 H-2  d   transgenic mice, whereas MRL/lpr 3-83 mice 
only showed a 10-fold reduction in MFI upon exposure to 
H-2  k  . Thus, the extent of down-regulation of IgM is fi  vefold 
less in the bone marrow of the MRL/lpr transgenic mice 
upon exposure to self-antigen. Furthermore, in the absence 
of exposure to self-antigen, the MFI of IgM on the immature 
B cells from MRL/lpr 3-83 mice is 40% lower than the MFI 
on immature B cells from B10.D2 transgenic mice. 
  RNA and DNA were isolated from MACS-purified 
B220  +   cells from transgenic mice of both strains on both anti-
genic H-2  k/d   and nonantigenic H-2  d   backgrounds.   Fig. 5 C   
shows that cells from MRL/lpr H-2  k/d   transgenic mice displayed 
  RAG mRNA production is stimulated only at very low 
concentrations of ionomycin in MRL/lpr immature B cells 
  It has been shown that immature B cells only up-regulated RAG 
mRNA after culture with low concentrations of ionomycin that 
produced minimal calcium fl  ux (  19  ). Because immature B cells 
from MRL/lpr mice show increased calcium fl  ux in response to 
BCR ligation or to low concentrations of ionomycin compared 
with immature B cells from B10.D2 mice, we hypothesized that 
RAG mRNA would only be induced at very low concentra-
tions of ionomycin in immature B cells from MRL/lpr mice. 
To test this hypothesis, we cultured bone marrow cells from 
both strains of transgenic mice with IL-7 for 5 d to obtain pure 
populations of immature B cells and then cultured the immature 
B cells with varying doses of ionomycin for 24 h. Cells were 
harvested, and the level of RAG2 mRNA was determined. In 
the B10.D2 transgenic mice, optimal RAG induction occurred 
at moderate concentrations of ionomycin (200 ng/ml;   Fig. 4  ), 
whereas for MRL/lpr transgenic mice, the optimal level of 
RAG   induction was far lower (0.5 ng/ml).   Thus, we propose 
that immature B cells from MRL/lpr mice may fail to up-
regulate RAG mRNA in the receptor-editing cultures because 
the signal they receive may already be beyond the maximum 
stimulation threshold for RAG mRNA induction. 
  Bone marrow cells from MRL/lpr BCR transgenic mice 
exhibit reduced responses to receptor-editing signals in vivo 
  Because the BCR light chain transgenes are not integrated 
into the light chain locus, these mice cannot undergo eff  ective 
receptor editing even if the transgene is expressed in mice bear-
ing an H-2 haplotype, such as H-2  k  , with which the BCR 
strongly reacts. However, the bone marrow cells in these 
mice can be analyzed for the same parameters of attempted 
receptor editing (i.e., RAG mRNA up-regulation and induc-
tion of endogenous      rearrangement) that we analyzed in the 
in vitro receptor-editing culture system. 
  Figure 4.     Level of RAG 2 mRNA expression after culture with ion-
omycin. Immature B cells from day 6 IL-7 cultures of B10.D2 and MRL/lpr 
(H-2  d  ) 3-83 bone marrow cells were cultured with varying concentrations 
of ionomycin for 24 h. RNA was prepared, and the cDNA was analyzed by 
real-time PCR. Results are   ±  SEM of six experiments.        Figure 3.     Immature B cells from MRL/lpr (H-2  d  ) 3-83 mice show 
stronger calcium fl  ux than immature B cells from B10.D2 3-83 
mice. Immature B cells were obtained from day 6 or 7 IL-7 cultures. 
 Calcium  fl  ux was measured by fl  ow cytometry with Indo-loaded cells. 
Results are representative of three experiments.     JEM VOL. 204, November 26, 2007 
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twofold less endogenous      and recombining sequence (RS) 
rearrangements than B10 H-2  k/d   transgenic mice. These fi  nd-
ings are very consistent with our in vitro receptor-editing 
culture results and provide further evidence of ineffi   cient re-
ceptor-editing responses to BCR ligation by self-antigen in 
autoimmune-prone MRL/lpr mice. 
  MRL/lpr 3-83 BCR transgenic mice undergo proper 
deletional central tolerance checkpoint controls in vivo 
  Although the transgenic mice cannot undergo much receptor 
editing (i.e., replacing the 3-83 BCR) even in the presence of 
strong self-antigen, it has been shown that a small percentage 
of cells do successfully inactivate the 3-83 transgenic light 
chain and emerge into the periphery as Id    −    IgM  +   B cells (  6  ). 
In addition, that study demonstrated that about half of the 
splenic B cells expressed      light chains. Thus, most transgenic 
B cells undergo deletion in the bone marrow, but the rare ones 
that successfully edit will emigrate to the spleen. In a sub-
sequent study, it was shown that this low frequency of successful 
receptor editing is true for transgenic mice on the MRL/lpr 
background (  16  ). 
  Here, we directly compared the spleen populations of the 
F1 H-2  k/d   3-83 transgenic mice on the MRL/lpr and B10 
background. Spleen cells from both strains of H-2  k/d   mice 
were analyzed by fl  ow cytometry for the presence of Ig      +   and 
Ig      +   as well as for Id  +   cells. Consistent with the previous studies, 
we did not observe any Id  +   cells in the spleens of either strain 
of mice (unpublished data). Furthermore, we confi  rmed that 
there is only a small number of B cells that have successfully 
receptor edited and emigrated from the bone marrow into 
the spleens of both strains of mice (  Table I  ).   
  We further investigated the spleens to determine if the 
MRL/lpr transgenic mice were specifi  cally defi  cient in mature 
B cells or if the proportion of transitional cells was higher in 
these mice. The immature B cell stage in the bone marrow is the 
fi  rst tolerance checkpoint, whereas the stage of emergence 
from the transitional compartment in the spleen to mature 
AA4    −    B cells is the second tolerance checkpoint (  1  ). Nontrans-
genic MRL/lpr mice have a much smaller proportion of AA4  +   
transitional cells than C57BL/6 mice, and this is also the case in 
the 3-83 transgenic mice on the H-2  d   background (  Table I  ). 
When the transgene is expressed on the antigenic H-2  k/d   
background, the percentage of transitional cells drops some-
what in both strains, although the decrease is proportionally 
less than half as much RAG mRNA up-regulation as a result 
of in vivo self-antigen exposure than B10 H-2  k/d   trans-
genic mice, suggesting that cells from MRL/lpr mice do not 
effi   ciently process the receptor-editing signals. Furthermore, 
MRL/lpr H-2  k/d   transgenic mice displayed approximately 
  Figure 5.     Bone marrow cells of MRL/lpr 3-83 transgenic mice on 
an antigenic H-2  k/d   background show less down-regulation of IgM 
and lower levels of receptor editing ex vivo. (A) FACS analysis of bone 
marrow cells from B10.D2 and MRL/lpr 3-83 mice on the nonantigenic 
H-2  d   background and on the antigenic H-2  k/d   background, as well 
as   nontransgenic littermates. Bone marrow cells were gated on the 
AA4  + B220 + CD43  −    population. The percentage of cells in each gate is shown. 
(B) IgM MFI   ±   SEM of AA4  + B220 + CD43  −    cells from eight experiments. 
(C) B220  +   MACS-purified bone marrow cells from B10.D2 and MRL/lpr 
H-2  k/d   3-83 transgenic mice were processed into DNA and cDNA. 
DNA was used for measurement of endogenous      re arrangements 
and RS rearrangements, and cDNA was used to quantitate RAG 1 and 
2 mRNA expression levels. For each of eight experiments, the level of 
rearrangements or RAG mRNA was compared between B10 and MRL/
lpr H-2   k/d   B220 +   cells, and the results are expressed as the mean   ±   
SEM of the level in the MRL/lpr B220  +   cells as a percentage of the 
level in the B10 cells.     
    Table I.        Percentage of B cells and light chain usage in the spleens of 3-83 transgenic mice 
B220  +   AA4  +   transitional cells B220  +   AA4    −    mature B cells
Strain    a    MHC % B cells    b   %        +          −  %        +        + %          −         + %        +          −  %        +        + %          −         + 
B10 d/d 41.23 99.6 0.05 0.01 99.06 0.28 0.52
B10 k/d 3.98 64.53 10.85 23.29 36.83 18.67 44.23
MRL/lpr d/d 26.86 99.48 0.02 0.02 99.72 0.02 0.06
MRL/lpr k/d 3.08 76.41 5.59 16.95 46.07 5.56 48.06
  a  3-83  transgenic  mice.
  b    B cells were identifi  ed as B220  + CD3  −    Ig +   cells. Data are the mean of fi  ve mice of each strain on the H-2  dd   background, and nine mice of each strain on the H-2  k/d   background.2858 REDUCED RECEPTOR EDITING IN MRL/  LPR   MICE | Lamoureux et al.
cells is higher in the B10 background, suggesting that more 
robust receptor editing is taking place in the transgenic mice 
on the B10 background. 
  CD19 expression is decreased in H-2  k/d   mice 
  In the FACS analysis of spleen cells from H-2  k/d   mice, we 
initially used CD19 to identify the B cells. Surprisingly, the 
MFI of CD19 was reduced twofold in the few B cells present 
in the MRL/lpr H-2  k/d   mice compared with splenic B cells 
from MRL/lpr 3-83 mice on the nonantigenic H-2  d   back-
ground (  Fig. 7 A  ).   The MFI of CD19 was also reduced in the 
splenic B cells of B10 H-2  k/d   transgenic mice compared with 
B10.D2 transgenic mice, but only by 20%. 
  We also analyzed the level of CD19 in the bone marrow 
cells of the receptor-editing H-2  k/d   mice. We found a dramatic 
reduction of CD19, but in a reciprocal pattern. B10 mice 
displayed a 10.5-fold reduction in the MFI of CD19, whereas 
MRL/lpr mice only showed a 4.5-fold reduction (  Fig. 7 B  ). 
Because B10 mice undergo more receptor editing in the bone 
marrow, the latter observation suggests that CD19 is down-
regulated during receptor editing in proportion to the extent 
of receptor editing. 
  In addition, we found that MRL/lpr immature B cells 
have consistently lower levels of CD19 in the bone marrow 
compared with B10 mice both for transgenic (on the nonan-
tigenic H-2  d   background) and nontransgenic mice (  Fig. 7 B  ). 
Thus, we fi  nd that receptor-editing results in down-regula-
tion of CD19 as well as IgM and, in agreement with our ob-
servation that B10 mice undergo more receptor editing than 
MRL/lpr mice, the extent of down-regulation of both CD19 
and IgM is greater in B10 transgenic bone marrow than in 
MRL/lpr bone marrow. Surprisingly, the MRL/lpr B cells 
larger in the B10 mice (  Table I  ). Interestingly, the AA4  +   tran-
sitional B cells, although completely Id    −    in both strains, have a 
much higher percentage of Ig      +   Ig        −    B cells (64  –  76%) than 
the mature AA4    −    B cells (37  –  46%) in both strains of mice. 
Because the spleen cells do not express RAG mRNA, the 
decrease in the proportion of Ig      +   Id    −    cells between the 
transitional and the mature B cell compartment must occur 
by deletion at this second tolerance checkpoint. The transi-
tional cells in the MRL/lpr transgenic mice have a lower 
percentage of Ig      +           −    cells, but the percentage of Ig      +           −    
cells in the mature B cells is similar in both strains. The pre-
dominant diff  erence between the B10 and MRL/lpr splenic 
B cells is that B10 mice have a higher percentage of Ig      +   Ig      +   
double-expressing cells in both the AA4  +   transitional cells 
and, even more strikingly, in the AA4    −    mature B cells (  Fig. 6   
and   Table I  ).   
  Because we observed a decrease in the percentage of Ig      +   
cells as the cells matured from the transitional compartment 
into the naive splenic compartment, we also analyzed the few 
IgM  +   bone marrow immature B cells in the H-2  k/d   F1 mice. 
In both strains, we found that the majority of IgM  +   cells ex-
pressed Ig     yet were Id    −    (unpublished data). As with the 
transitional splenic compartment, the percentage of Ig      +   cells 
was higher in the MRL/lpr immature B cells than in the rare 
B10 immature B cells. 
  These fi  ndings demonstrate that the deletion mechanism 
of tolerance is intact for the MRL/lpr H-2  k/d   transgenic mice 
at both the fi  rst tolerance checkpoint (immature bone marrow 
B cells) and at the second checkpoint (transitional to naive 
B cell in the spleen), in that all B cells that emerge in the 
periphery in both strains of mice are Id    −   . However, the pro-
portion of Ig      +   Ig      +   double-expressing cells and of Ig        −    Ig      +   
  Figure 6.          and      light chain expression in spleen cells of 3-83 transgenic mice on the H-2  k/d   and H-2  d   background. Spleen cells from B10 
and MRL/lpr transgenic mice were surface stained with antibodies reactive with B220, AA4, CD3,     , and    .  B220 + CD3  −    cells were divided into AA4  +   and 
AA4   −    gates and then analyzed for      and      staining.  B220 + Ig  −    cells were gated out. The percentage of cells in each gate is shown. FACS profi  les shown of 
the AA4   −    spleen cells are representative of fi  ve experiments with several mice per experiment. The results from all of the mice in all experiments are tabu-
lated  in   Table  I .   JEM VOL. 204, November 26, 2007 
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  One assay to indicate if MRL/lpr mice undergo less re-
ceptor editing in vivo is to measure the transit time through 
the pre  –  B cell compartment. It has been shown that cells 
undergoing receptor editing are delayed in their transit time 
through the pre  –  B cell compartment (  10, 13  ). A single BrdU 
injection will label the large pre  –  B cells that are undergo-
ing extensive proliferation as a result of pre-BCR signaling. 
Hence, one can follow those labeled cells and determine the 
time course of accumulation of BrdU-labeled cells in the im-
mature B cell compartment. If receptor editing is taking place at 
a lower frequency in autoimmune-prone mice, we would pre-
dict that the cells from MRL/lpr mice would transit more rap-
idly through the pre  –  B cell stage because not as many of the 
cells would be returned there to undergo receptor editing. 
  To test this, MRL/lpr and C57BL/6 mice were injected 
i.p. with BrdU and analyzed at various time points by fl  ow 
cytometry. It can be seen that the proportion of BrdU-labeled 
immature B cells rises much faster in MRL/lpr than in B6 
mice (  Fig. 8  ).   This shorter transit time through the pre  –  B cell 
compartment is consistent with the hypothesis that MRL/lpr 
mice undergo less receptor editing in vivo. 
  Defect in receptor editing is not caused by the   lpr   mutation 
  To determine if the defect in receptor editing is caused by the 
  lpr   mutation in the   Fas   gene, we also used BrdU to determine 
the kinetics of B cell development in the bone marrow of 
MRL/+ mice and compared the results with those of MRL/lpr 
mice.   Fig. 8   shows that the kinetics of appearance of BrdU-
labeled immature B cells is similar in both of these strains, sug-
gesting that the lower level of receptor editing in MRL/lpr 
mice is not caused by the defect in the   Fas   gene. 
    DISCUSSION   
  Although it is generally agreed that the breakdown of toler-
ance and activation of autoreactive B cells in lupus primarily 
occurs in the periphery, we present evidence that there is also 
a defect in central tolerance in lupus-prone mice. The bone 
marrow central tolerance checkpoint can be accomplished by 
either receptor editing or by clonal deletion. In nonautoimmune 
strains of mice, receptor editing has been shown to be the major 
mechanism of B cell tolerance in the bone marrow (  4, 13  ), 
but there are little data to distinguish whether autoimmune-
prone mice undergo less receptor editing in situations where 
clonal deletion may compensate for ineffi   cient receptor editing 
and, thus, mask this potentially important defect. 
  In this study, we use a well-established in vitro system to 
measure defi  ned classic parameters of receptor editing (i.e., 
up-regulation of RAG mRNA and induction of endogenous 
light chain rearrangement) to demonstrate that MRL/lpr 
lupus-prone mice have a less robust receptor-editing response 
to BCR ligation at the immature B cell stage (  18  ). Because the 
BCR is encoded by heavy and light chain transgenes that are 
not targeted into the heavy and light chain loci in the mice 
we used in this study, eff  ective receptor editing per se cannot 
occur, but these parameters give an excellent readout of the at-
tempted response of immature B cells to receptor-editing signals. 
maintain a suppressed level of CD19 in mature splenic cells 
after the cessation of receptor editing, whereas the B10 mice 
revert to almost normal levels. 
  Surface CD19 levels decrease in receptor-editing cultures 
  In the in vitro receptor-editing cultures, we also observed a de-
crease in surface expression of CD19 in the cells cultured with 
anti-Id compared with the control cultures, which was consis-
tent with the hypothesis that this decrease is a refl  ection of re-
ceptor editing (  Fig. 7 C  ). However, the extent of this decrease 
was much less than that observed in vivo. As with the decrease 
in IgM in the culture system, the relative decrease in CD19 was 
similar between the two strains of mice, even though the MRL/
lpr transgenic mice underwent less receptor editing in vitro. 
However, the level of IgM and CD19 in the day 5 IL-7 cultures 
is 25 and 40% less, respectively, in the MRL/lpr immature B cells 
than in those from the B10 transgenic cultures (  Figs. 2 and 7 C  ). 
  Transit time through the pre  –  B cell compartment is faster 
for MRL/lpr mice 
  The data presented so far is limited to BCR transgenic mice. 
Determining whether nontransgenic lupus-prone mice have 
a defect in receptor editing in vivo is less straightforward to 
analyze. These mice have a vast array of diff  erent antigen re-
ceptors with a wide range of affi   nities for a host of soluble and 
membrane-bound self-antigens. 
  Figure 7.     Modulation of CD19 levels after exposure to self-antigen. 
(A) Spleen cells from H-2  k/d   and  H-2 d   transgenic mice were gated on 
B220  + CD3  −  CD19 +   cells, and the MFI   ±   SEM of CD19 from fi  ve experiments 
is shown. (B) Bone marrow cells from the same mice were gated on 
B220  + CD43  −  AA4 +   cells, and the MFI   ±   SEM of CD19 is shown. (C) The MFI 
of CD19 on immature B cells from bone marrow cultures with IL-7 or 
from day 2 after the transfer into the anti-Id (receptor-editing culture) or 
control culture conditions. Results are   ±  SEM.     2860 REDUCED RECEPTOR EDITING IN MRL/  LPR   MICE | Lamoureux et al.
receptor-editing process in response to in vivo exposure to 
H-2K  k   will fi  rst create endogenous      rearrangements, and 
that some of the       +   cells that have undergone a fi  rst round of 
receptor editing may still have some reactivity to self-antigen 
with their new receptors, stimulating continued receptor ed-
iting. The subset of cells with lower self-reactivity would 
then emigrate to the spleen but should be deleted in the tran-
sitional stage, resulting in a mature splenic population that is 
depleted of all self-reactive cells. Our data clearly show that 
the population of receptors in the immature transitional com-
partment is very diff  erent from that of the naive AA4    −    splenic 
B cell compartment; hence, it must be the case that clonal 
deletion is taking place between the transitional and the naive 
B cell compartments, because there is no RAG expression at 
this stage. 
  The fact that MRL/lpr H-2  k/d   transgenic mice have a 
higher proportion of       +   cells in both the bone marrow im-
mature B cell compartment and in the splenic transitional 
compartment than the B10 H-2  k/d   mice suggests that recep-
tor editing is not occurring as frequently in the MRL/lpr mice; 
therefore, we propose that more of the lower affi   nity self-re-
active immature B cells from MRL/lpr mice are leaving the 
bone marrow. This suggests that the threshold for permitting 
immature B cells to leave the bone marrow in MRL/lpr 
mice is less stringent than the threshold in B10 mice, and these 
self-reactive B cells that emigrate to the spleen in MRL/lpr 
mice could be a reservoir of potentially pathogenic autoreactive 
B cells. 
  Another major diff  erence between the peripheral B cells 
in the two strains of mice is that the B10 transgenic H-2  k/d   
mice have a higher proportion of      and      double-expressing 
cells than the MRL mice. This is reminiscent of the studies of 
Li et al. with the 3H9/56R anti-DNA heavy chain knock-in 
mice (  26, 27  ). The 3H9/56R H chain creates an anti-DNA 
receptor with most light chains, except for those encoded 
by a few V     genes termed   “  V     editors,  ”   and V    x. When the 
anti-DNA heavy chain was present on the BALB background, 
all peripheral B cells either expressed a light chain using a V     
editor, or coexpressed both a V     editor and a      receptor on 
their surface, each at half the normal surface density of IgM (  27  ). 
Furthermore, we used these same parameters of receptor editing 
to demonstrate that receptor editing is also less effi   cient even 
in response to strong stimulation by ubiquitously expressed 
membrane-bound self-antigen in vivo. In the latter case, 
however, clonal deletion is very eff  ective, and thus, no Id  +   
cells can be found in the periphery. 
  There are data in the literature consistent with our hypoth-
esis that autoimmune individuals have less effi   cient central 
tolerance mechanisms. Older studies have proposed that hu-
mans with autoimmune diseases have either a decreased or an 
increased incidence of receptor editing, using parameters such 
as the increased usage of downstream J     or J     genes (  21  –  25  ). 
More recently, Yurasov et al. analyzed the repertoire of newly 
emigrated and mature naive cells from the peripheral blood 
of SLE patients, demonstrating that this second tolerance check-
point is much less eff  ective in SLE patients (  14  ). The fi  rst tol-
erance checkpoint occurs in the bone marrow and, thus, was not 
directly investigated in the lupus patients. However, in previ-
ous work, these investigators showed that the autoimmune 
and polyreactive profi  les of the late immature B cells from 
the bone marrow resembled the peripheral blood new emi-
grants (  1  ). The new emigrant B cells in the SLE patients had 
a slightly higher proportion of polyreactive and autoreactive 
cells than controls, which is suggestive of a defect in an early 
tolerance checkpoint. Whether this potential defect is caused 
by less effi   cient receptor editing or less effi   cient clonal deletion 
was not investigated in that study. 
  In agreement with previously published studies, we ob-
served that the few B cells that were found in the spleen of 
either MRL/lpr or B10 3-83 transgenic mice on the anti-
genic H-2  k/d   background had all undergone receptor editing, 
as demonstrated by the complete absence of Id  +   cells in the 
spleen and also by the presence of a large proportion of       +   
cells (  6, 16  ). Surprisingly, however, the transitional B cells ex-
pressed a much higher proportion of       +   cells than the mature 
AA4    −    cells, and importantly, the MRL/lpr transitional cells 
expressed an even higher percentage of       +   cells than the B10 
transitional cells. In the bone marrow, the majority of imma-
ture B cells, which are all Id    −   , are       +  . Because it is known that 
     alleles rearrange before      alleles, we hypothesize that the 
  Figure 8.     Transit time through the pre  –  B cell compartment is faster in the bone marrow of MRL/lpr and MRL/+ mice as compared with B6 
mice. Nontransgenic B6, MRL/lpr, and MRL/+ mice were injected once i.p. with BrdU and analyzed at various time points. Cells were surface stained, per-
meabilized, and stained with FITC-BrdU to determine transit time through the pre  –  B cell compartment. The percentage of BrdU-labeled immature B cells 
from each mouse is plotted. The horizontal bar represents the mean of each time point.     JEM VOL. 204, November 26, 2007 
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  In the spleens of transgenic or nontransgenic MRL/lpr 
and B10 mice, we observed similar levels of CD19 expression 
between the two strains. This is in contrast to one study of 
SLE patients in which it was shown that naive peripheral 
blood B cells from SLE patients have a 20% lower MFI of 
CD19 than healthy controls (  33  ), though another study did 
not show much diff  erence in CD19 expression (  34  ). In con-
trast, nontransgenic MRL/lpr mice have lower levels of CD19 
and IgM than B10 mice in immature B cells. The lower MFI 
of both IgM and CD19 on bone marrow immature B cells 
from MRL/lpr mice might suggest that they receive a weaker 
signal through engagement of their BCR with self-antigen 
than immature B cells from B10 mice. This weaker signal 
could contribute to the less eff  ective receptor-editing response. 
However, our data showing increased calcium fl  ux in imma-
ture B cells from MRL/lpr mice demonstrate that the expla-
nation is more complex. To our knowledge, this is the fi  rst 
demonstration of increased calcium fl  ux in bone marrow im-
mature B cells in lupus mice. These data are consistent with 
previous observations in peripheral blood B cells from SLE 
patients in which IgM cross-linking results in increased calcium 
fl  ux and increased tyrosine phosphorylation of signaling pro-
teins (  35, 36  ). Peripheral T cells from MRL/lpr mice have 
also been demonstrated to be hyperresponsive to stimulation 
through their TCR (  37  ). Because we observed that immature 
B cells from IL-7  –  driven cultures of MRL/lpr mice are hyper-
responsive with regard to the extent of calcium mobilization 
after either ionomycin or anti-IgM stimulation, this suggests 
that the hyperresponsiveness is downstream of IgM. 
  Hyperresponsiveness to BCR stimulation may have con-
trasting eff  ects for peripheral versus immature B cells. It is 
known that there are many diff  erences in the way that im-
mature and mature splenic B cells respond to BCR ligation, 
which could be caused by diff  erences in the level of individ-
ual proteins involved in signaling cascades, or whether the 
BCR signals from inside or outside lipid rafts (  19, 38, 39  ). In the 
periphery, hyperresponsiveness may lead to inappropriate 
activation of low affi   nity self-reactive cells. However, hyper-
responsiveness may be a detriment in immature bone marrow 
cells. It is possible that the immature B cells from MRL/lpr 
mice are receiving too strong a signal to up-regulate RAG 
mRNA. It has been shown that immature 3-83 transgenic 
B cells from IL-7 cultures only up-regulate RAG mRNA when 
they are stimulated with concentrations of ionomycin that are 
so low that they barely elicit a calcium fl  ux response (  19  ). To 
test the hypothesis that MRL/lpr may have too strong a response 
to IgM or ionomycin stimulation, we cultured immature B cells 
from both strains of mice with varying concentrations of 
ionomycin. Consistent with our hypothesis, immature B cells 
from MRL/lpr mice up-regulated RAG mRNA at much 
lower concentrations of ionomycin than immature B cells 
from B10 mice. It may be the case that the receptor-editing 
and apoptosis/clonal deletion signals may go through two 
diff  erent pathways, and that the clonal deletion/apoptosis sig-
naling pathway is functioning very well in MRL/lpr mice, at 
least with regard to strong membrane-bound antigens. 
In the latter case, the      receptor would generate an anti-
DNA specifi  city, but because the cells coexpressed a V     edi-
tor, the innocuous BCR expressing the V     editor light chain 
may have allowed the exit of these potentially autoreactive B 
cells from the bone marrow. The lower level of       +   BCR on 
the surface may prevent the double expressers, which ac-
count for     30% of the splenic B cell population in these 
mice, from becoming activated by self-antigen. In contrast, 
when the same 3H9/56R heavy chain was present on the 
MRL/lpr background, no    /     double expressers were observed. 
Similarly, we also observed a higher proportion of     /     double 
expressers in the nonautoimmune B10 3-83 H-2  k/d   mouse strain 
than in the MRL/lpr transgenic mice. Furthermore, some 3H9/
56R cells were found that express only     1, and thus bound 
DNA, in the MRL/lpr transgenic mice (  26  ). The fact that these 
cells were found in the periphery suggests a defect in central tol-
erance in the MRL/lpr, but not BALB/c, 3H9/56R transgenic 
mice, reinforcing our hypothesis that the threshold for exit of 
low affi   nity self-reactive B cells from the bone marrow may be 
lower for MRL/lpr than for nonautoimmune mice. It may 
be that the hyperactivity of the immature B cells in MRL/lpr 
mice (  Fig. 3  ) results in their exit from the bone marrow before 
appropriate receptor editing has been completed. 
  CD19 is an important coreceptor in the BCR signaling 
complex, and a reduction in the expression of CD19 can re-
sult in less robust BCR signaling in mature B cells (  28  –  30  ). 
CD19 also functions in immature B cells. In the CD19    −  /  −    3-83 
transgenic mice on the nonantigen B10.D2 background, 
receptor editing was greatly stimulated (  31  ). Signals generated 
through CD19 are critical for activation of phosphoinositide 
3-kinase, which generates PIP3 and suppresses RAG mRNA 
expression (  32  ). In immature B cells receiving a receptor-editing 
signal, the level of PIP3 falls and RAG mRNA levels remain 
high. We analyzed the level of CD19 in the bone marrow 
cells of the transgenic MRL/lpr and B10 H-2  k/d   mice that 
receive strong receptor-editing signals in vivo. We observed 
substantial down-regulation of both CD19 and IgM after 
BCR cross-linking. Importantly, however, the extent of down-
regulation of both CD19 and IgM was far greater in the B10 
mice than in the MRL/lpr mice, which was consistent with 
our hypothesis that MRL/lpr mice undergo less receptor ed-
iting. Thus, the extent of down-regulation of CD19, which 
likely aff  ects intracellular PIP3 levels, appears to be proportional 
to the extent of receptor editing. 
  We observed much more modest down-regulation of CD19 
in the in vitro IL-7 culture system, where BCR cross-linking 
was induced by anti-Id antibody, mimicking soluble antigen. 
We attribute this modest CD19 down-regulation to the weaker 
signal presumably given by soluble versus membrane-bound 
antigen. In agreement with this, the extent of IgM down-
regulation is also less in the cultured immature B cells than in 
the bone marrow in vivo. This suggests that the dramatic down-
regulation of IgM and CD19 in the bone marrow of mice ex-
posed to membrane-bound self-antigen is indicative of the 
increased strength of the interaction with the ubiquitously 
expressed cell-surface MHC class I molecule. 2862 REDUCED RECEPTOR EDITING IN MRL/  LPR   MICE | Lamoureux et al.
the IL-7 is removed, and cells are washed and recultured in IMDM media 
plus either an anti-Id antibody (S23), which is specifi  c for the 3-83 BCR, or 
nonreactive control antibody (Y3) for 48 h. Cells are removed at 24 and 48 h 
and processed for DNA and RNA. In addition, an aliquot of the cells is left 
in IL-7  –  supplemented IMDM media. Data are expressed as the fold increase 
in cultures with anti-Id compared with the IL-7 cultures, or fold increase in 
control cultures compared with the IL-7 cultures. 
  DNA/RNA/complementary DNA (cDNA).     DNA and RNA were ex-
tracted from cells as per the manufacturer  ’  s instructions (QIAGEN). cDNA 
was made from RNA extractions as per manufacturer  ’  s instructions using the 
Super Script II kit (Invitrogen). 
  Quantitative real-time PCR.         rearrangements (5   -  GGCTGCAGSTTCA- 
GTGGCAGTGGAT-  3     and 5    -  GCCACAGACATAGACAACGGAA  GAA  -3    ), 
levels of RAG mRNA (Rag 1, 5    -  CATTCTAGCACTCTGGCCGG  -3     
and 5    -  TCATCGGGTGCAGAACYGAA  -3    ; Rag 2, 5    -  TTAATTCCT-
GGCTTGGCCG  -3     and 5    -  TTCCTGCTTGTGGATGTGAAAT-  3    ), 
and RS rearrangements (IRS1, 5    -CATTTGGCGTTCACCCTGCC-3    ; 
RS-3    , 5    -TGTTTTCCTGGAGCTCCTCAGG-3    ) were assessed by real-
time PCR using a sequence detection system (ABI 7900; Applied Biosytems) 
and a Quantitec SYBR PCR kit (QIAGEN). PCR conditions were as fol-
lows: 95  °   for 15 min, cycled 45 times at 94  °   for 15 sec, 60  °   for 30 sec, and 
72  °   for 30 sec. All samples were normalized to actin, either DNA or cDNA, 
by real-time PCR analysis using the     CT calculation. The following actin 
primers were used: DNA actin (5   -  AGGCATGGAGTCCTGTGGTATC-  3     
and 5   -  AGCCACAGGTCCTAAGGCCAG  -3    ) and cDNA actin (5   -  TCT-
GGCTCCTAGCACCATGAAGA  -3     and 5    -  GGGACTCATCGTAC-
T  C  CTGCTTG  -3    ). Data are expressed as     CT or as fold increase using 
the formula 2      CT  . 
  Ionomycin cultures.     Cells from day 5 IL-7 cultures were washed and cul-
tured with varying concentrations of ionomycin (Sigma-Aldrich) for 24 h. 
Cells were then harvested and RNA was prepared. 
  Calcium fl  ux.     Cultured bone marrow cells were incubated with 20     M 
Indo-1 AM (Invitrogen) in loading solution for 45 min at 37  °  C. Cells were 
then washed and subsequently stimulated with varying concentrations of a 
F(ab    )  2   fragment of donkey anti  –  mouse IgM (Jackson ImmunoResearch 
Laboratories) or ionomycin. Measurement of the amount of intracellular 
calcium fl  ux after stimulation was performed for 8 min on a digital fl  ow 
cytometer (LSR II; BD Biosciences). 
  Flow cytometric analysis and cell sorting.     Cells from the bone marrow 
and spleen were stained for various cell-surface markers. Bone marrow cells 
were stained for anti  –  mouse CD43-FITC (BD Biosciences), IgM-PE (eBio-
science), AA4-allophycocyanin (APC; eBioscience), and CD19  –  Pacifi  c blue 
(Biolegend) or B220-PeCy7 (Biolegend). Spleen cells were stained using 
varying combinations of anti  –  mouse CD19-APC or Pacifi  c blue, or B220-
PeCy7, IgM-PE, IgD-FITC (Biolegend),     -PE (BD Biosciences),     -biotin 
(BD Biosciences), AA4-APC, CD21-FITC (BD Biosciences), CD23-PE 
(Biolegend), or biotin-conjugated anti-Id. Biotinylated antibodies were de-
tected using streptavidin-conjugated Pacifi  c blue or APC (Biolegend). Cells 
were analyzed using an LSR II or a FACSCalibur instrument (BD Biosci-
ences) and FlowJo software (Tree Star, Inc). Cell sorting was performed on 
either a FACSVantage DiVa or FACSAria (both from BD Biosciences). 
  MACS purifi  cation.     B220  +   cells were purifi  ed from the bone marrow by 
staining with anti-B220 conjugated with PE, followed by positive purifi  cation 
of the cells on an anti-PE column according to the manufacturer  ’  s instruc-
tions (Miltenyi Biotec). 
  BrdU labeling.     Mice were injected once i.p. with 100     l (10 mg/ml) of 
BrdU (BD Biosciences) and killed at the time points indicated in the 
  figures. Bone marrow was isolated, stained for the surface markers IgM 
  Many lupus susceptibility loci have been identifi  ed, but it 
is unlikely that any of the ones described thus far control the 
receptor-editing defect that we describe in this paper (  40, 41  ). 
The only genetic interval that may aff  ect receptor editing 
is the   Sle1b   locus of the NZM2410 strain. Recently, it has 
been shown that one key polymorphic gene within this re-
gion is   Ly108  , a signaling lymphocyte activation molecule 
family member (  42, 43  ). Transfection of the Ly108.1 isoform 
of this gene into an immature B cell line, WEHI 231, results 
in less RAG up-regulation after BCR cross-linking than 
transfection of the Ly108.2 isoform. B6 mice express more of 
the Ly108.2 isoform, whereas B6.  Sle1b  z     mice express more 
of the Ly108.1 isoform. This suggests that this   Sle1b   lupus 
susceptibility gene may aff  ect receptor editing, although the 
eff  ect of the Ly108 polymorphism in controlling RAG mRNA 
levels in vivo in B6 versus B6.  Sle1b  z     congenic mice was not 
assayed. However, expression of the Ly108.1 allele results 
in less calcium fl  ux in immature B6.  Sle1b  z     B cells after BCR 
cross-linking, which is the opposite of what we observed in 
the immature B cells from MRL/lpr mice. Thus, there must 
be diff  erent susceptibility genes controlling the poor RAG 
up-regulation in the WEHI Ly108.1 transfectants and in the 
MRL/lpr mice. 
  In conclusion, we suggest that immature B cells from MRL/
lpr mice make less eff  ective responses to engagement of their 
receptors with self-antigen. They are less effi   cient at up-regu-
lating RAG mRNA, and they down-regulate surface IgM and 
its coreceptor CD19 less effi   ciently than B10 transgenic cells. 
The faster transit time of B cell precursors through the pre  –  B 
cell compartment from nontransgenic MRL/lpr and MRL/+ 
mice is consistent with the hypothesis that polyclonal, non-
transgenic MRL mice undergo less receptor editing in vivo 
to a wide variety of normal self-antigens. The MRL background 
must contribute genes that allow these less appropriate res-
ponses to self-antigen at this critical tolerance checkpoint, 
resulting in a higher proportion of B cells that may leave the 
bone marrow and emigrate to the periphery, where they 
can be activated by exposure to antigen, eventually resulting in 
autoimmune disease. 
  MATERIALS AND METHODS 
  Mice.     Mice were maintained in The Scripps Research Institute (TSRI) animal 
resources facility according to TSRI  ’  s Institutional Animal Care and Use guide-
lines. All experimental mice were between 6  –  9 wk of age. The generation of 
the MRL/lpr 3-83 transgenic mice on the H-2  d/d   background was previously 
described (  8  ). Mice were used at the seventh and eighth generations. To pro-
duce the MRL/+ H-2  d/d   3-83 transgenic mice, MRL/lpr (H-2  d/d  ) 3-83 trans-
genic mice were backcrossed onto MRL/+ (H-2  k  ) mice and screened to obtain 
transgenic mice homozygous for the wild-type   Fas   allele and for H-2  d  . 
  To study the extent of receptor editing in vivo, B10.D2 and MRL/lpr 
H-2  d/d   3-83 transgenic mice were crossed with either B10.BR (H-2  k  ) or 
MRL/lpr (H-2  k  ) mice, respectively, and H-2  k/d   F1 off  spring were screened 
for the presence of the transgene. Animals that were transgene positive were 
used for analysis. 
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